Donepezil Not Yet Recruiting Phase 4 Trials for OSAS (Obstructive Sleep Apneas Syndrome) / Somnolence Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03299257Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep Apnea